{"mainPropery":{"diseaseId":10684,"diseaseName":"Primary lateral sclerosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10684/primary-lateral-sclerosis","synonyms":["Adult-onset PLS","Adult-onset primary lateral sclerosis"],"synonyms-with-source":[{"name":"Adult-onset PLS","source":"OrphaData.Org"},{"name":"Adult-onset primary lateral sclerosis","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"611637"},{"identifierType":"ORPHANET","identifierId":"35689"},{"identifierType":"UMLS","identifierId":"C0154682"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":61,"resourceName":"Spastic Paraplegia Foundation","abbreviation":"SPF","address1":"1605 Goularte Place","address2":"","address3":"","address4":"","address5":"","city":"Fremont","state":"CA","zip":"94539-7241","country":"United States","phone":"1-877-773-4483 ","tty":"","tollFree":"","fax":"1-877-773-4483 ","email":"information@sp-foundation.org","url":"https://sp-foundation.org/","freeText":""},{"resourceID":597,"resourceName":"Motor Neurone Disease Association","address1":"PO Box 246","address2":"Northampton Intl NN1 2PR","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"44 160 4 250505","tty":"","tollFree":"","fax":"","email":"enquiries@mndassociation.org","url":"http://www.mndassociation.org"},{"resourceID":2652,"resourceName":"The ALS Association","abbreviation":"","address1":"1275 K Street, N.W.","address2":"Suite 250","address3":"","address4":"","address5":"","city":"Washington, DC","state":"","zip":"20005","country":"","phone":"202-407-8580","tty":"","tollFree":"1-800-782-4747","fax":"202-464-8869","email":"alsinfo@alsa-national.org","url":"http://www.alsa.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/611637' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=primary%20lateral%20sclerosis%5Bti%5D%20AND%20%28%22review%22%5BPublication%20Type%5D%20OR%20%22review%20literature%20as%20topic%22%5BMeSH%20Terms%5D%20OR%20%22review%22%5BAll%20Fields%5D%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Primary lateral sclerosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Primary+lateral+sclerosis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Primary lateral sclerosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":111,"resourceId":972,"resourceName":"Centers for Mendelian Genomics","descriptionText":"The <a href='http://mendelian.org/' target='_blank'>Centers for Mendelian Genomics</a> program is working to discover the causes of rare genetic disorders. For more information about applying to the research study, please visit their website.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":775,"resourceId":1860,"resourceName":"Mayo Clinic","descriptionText":"<a href='http://www.mayoclinic.org/diseases-conditions/primary-lateral-sclerosis/home/ovc-20214446' target='_blank'>Mayo Clinic</a> has an information page on Primary lateral sclerosis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/primary-lateral-sclerosis/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Primary-Lateral-Sclerosis-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1171782-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=35689' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1742,"resourceId":2896,"resourceName":"RDCRN - Clinical Research in Amyotrophic Lateral Sclerosis and Related Disorders for Therapeutic Development","descriptionText":"The <a target=\"_blank\" href=\"https://www.rarediseasesnetwork.org/CREATE/index.htm\">Clinical Research in Amyotrophic Lateral Sclerosis and Related Disorders for Therapeutic Development (CREATE) Consortium</a> is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research involving sporadic and familial forms of amyotrophic lateral sclerosis, frontotemporal dementia (FTD), primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), and progressive muscular atrophy (PMA). The CREATE Consortium has a contact registry for patients who wish to be contacted about clinical research opportunities and updates on the progress of the research projects.\r\n<br />\r\n<br />\r\nFor more information on the registry see: <a target=\"_blank\" href=\"https://www.rarediseasesnetwork.org/registry/index.htm\">https://www.rarediseasesnetwork.org/registry/index.htm</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:230' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":2963,"questionText":"What is primary lateral sclerosis?","answerText":"<strong>Primary lateral sclerosis (PLS)</strong> is a rare <a href=\"https://medlineplus.gov/neuromusculardisorders.html\" target=\"_blank\">neuromuscular disease</a> that affects the nerve cells that control the voluntary muscles. Problems in the legs (such as weakness, stiffness, <a href=\"http://www.ninds.nih.gov/disorders/spasticity/spasticity.htm\" target=\"_blank\">spasticity</a>, and balance problems) are often observed first, but hand clumsiness and changes in speech can be early symptoms, as well. The condition is progressive (gradually becomes worse over time); however, affected people have a normal life expectancy. The underlying cause of adult PLS is currently unknown. In most cases, it occurs sporadically in people with no family history of the condition. A subtype of PLS, called <a href=\"https://rarediseases.info.nih.gov/diseases/4485/juvenile-primary-lateral-sclerosis\" target=\"_blank\">juvenile PLS</a>, is caused by changes (mutations) in the <a href=\"https://ghr.nlm.nih.gov/gene/ALS2\" target=\"_blank\">ALS2</a> gene and is inherited in an autosomal recessive manner. Treatment is based on the signs and symptoms present in each person.[13323][13324][13325]","dateModified":"2017-04-14T00:00:00"},"basicQuestions":[{"questionId":4257,"questionText":"What are the signs and symptoms of primary lateral sclerosis?","answerText":"The signs and symptoms of primary lateral sclerosis (PLS) often develop between the ages of 40 and 60 and progress (become worse) over time. The voluntary muscles of the legs are often involved first, with symptoms beginning in one leg and then progressing to the other. In general, people with PLS may experience:[13323][13324][13325]<br />\r\n<ul>\r\n    <li>Muscle weakness</li>\r\n    <li>Muscle stiffness and spasticity</li>\r\n    <li>Difficulty&nbsp;with balance and clumsiness</li>\r\n    <li>Slowed movement</li>\r\n    <li>Problems with speech</li>\r\n</ul>","dateModified":"2017-04-13T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":13323,"authors":"","articleTitle":"Primary lateral sclerosis (PLS)","bookWebsiteJournalTitle":"Mayo Clinic","date":"October 2016","volume":"","pages":"","url":"http://www.mayoclinic.org/diseases-conditions/primary-lateral-sclerosis/symptoms-causes/dxc-20214456","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13324,"authors":"Carmel Armon, MD, MSc, MHS","articleTitle":"Primary Lateral Sclerosis","bookWebsiteJournalTitle":"Medscape Reference","date":"December 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1171782-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13325,"authors":"","articleTitle":"Primary Lateral Sclerosis Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke","date":"","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Primary-Lateral-Sclerosis-Information-Page","dateAccessed":"2017-04-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4259,"questionText":"How is primary lateral sclerosis diagnosed?","answerText":"A diagnosis of primary lateral sclerosis (PLS) may be suspected based on the presence of characteristic signs and symptoms. Several different medical tests may then be ordered to confirm the diagnosis and rule out other conditions (such as <a href=\"https://rarediseases.info.nih.gov/diseases/10255/multiple-sclerosis\" target=\"_blank\">multiple sclerosis</a> and <a href=\"https://rarediseases.info.nih.gov/diseases/5786/amyotrophic-lateral-sclerosis\" target=\"_blank\">amyotrophic lateral sclerosis</a>) that can be associated with similar features. These tests may include:[13323][13324]<br />\r\n<ul>\r\n    <li>Blood work</li>\r\n    <li>Magnetic resonance imaging (MRI) of the brain and spine\r\n    </li>\r\n    <li>Motor and sensory <a href=\"http://www.hopkinsmedicine.org/healthlibrary/test_procedures/neurological/nerve_conduction_velocity_ncv_92,P07657/\" target=\"_blank\">nerve conduction studies</a>\r\n    </li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003929.htm\" target=\"_blank\">Electromyogram (EMG)</a>\r\n    </li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003369.htm\" target=\"_blank\">Cerebrospinal fluid (CSF) analysis</a></li>\r\n</ul>\r\nAlthough a preliminary diagnosis of PLS can be made after other conditions are ruled out, it may take repeated testing over three to four years to confirm the diagnosis.[13323]","dateModified":"2017-04-13T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":13323,"authors":"","articleTitle":"Primary lateral sclerosis (PLS)","bookWebsiteJournalTitle":"Mayo Clinic","date":"October 2016","volume":"","pages":"","url":"http://www.mayoclinic.org/diseases-conditions/primary-lateral-sclerosis/symptoms-causes/dxc-20214456","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13324,"authors":"Carmel Armon, MD, MSc, MHS","articleTitle":"Primary Lateral Sclerosis","bookWebsiteJournalTitle":"Medscape Reference","date":"December 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1171782-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11781,"questionText":"How might primary lateral sclerosis be treated?","answerText":"The treatment of primary lateral sclerosis (PLS) is based on the signs and symptoms present in each person. For example, certain medications may be prescribed to treat the muscle stiffness and/or pain that can be associated with the condition. Physical therapy and occupational therapy can help maintain muscle strength, flexibility and range of motion, and may prevent joint immobility. Assistive devices such as braces, canes, walkers or wheelchairs may be needed for continued mobility. Speech therapy may be recommended when facial muscles are involved.[13323][13324][13325]","dateModified":"2017-04-14T15:06:00","resourceClassificationName":"Treatment","references":[{"referenceId":13323,"authors":"","articleTitle":"Primary lateral sclerosis (PLS)","bookWebsiteJournalTitle":"Mayo Clinic","date":"October 2016","volume":"","pages":"","url":"http://www.mayoclinic.org/diseases-conditions/primary-lateral-sclerosis/symptoms-causes/dxc-20214456","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13324,"authors":"Carmel Armon, MD, MSc, MHS","articleTitle":"Primary Lateral Sclerosis","bookWebsiteJournalTitle":"Medscape Reference","date":"December 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1171782-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13325,"authors":"","articleTitle":"Primary Lateral Sclerosis Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke","date":"","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Primary-Lateral-Sclerosis-Information-Page","dateAccessed":"2017-04-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13748,"phenoTypeName":"Abnormal upper motor neuron morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13598,"phenoTypeName":"Babinski sign","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3542,"phenoTypeName":"Generalized hyperreflexia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13564,"phenoTypeName":"EMG: chronic denervation signs","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6355,"phenoTypeName":"Loss of speech","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9759,"phenoTypeName":"Progressive spastic paraparesis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13872,"phenoTypeName":"Pseudobulbar signs","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5224,"phenoTypeName":"Spastic dysarthria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13452,"phenoTypeName":"Spastic gait","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5137,"phenoTypeName":"Cervical spinal cord atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4476,"phenoTypeName":"Motor axonal neuropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6254,"phenoTypeName":"Adult onset","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","percentRanges":"-"},{"phenoTypeId":5256,"phenoTypeName":"Slow progression","percentRanges":"-"},{"phenoTypeId":9378,"phenoTypeName":"Spastic tetraparesis","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Primary_lateral_sclerosis"}